{"id":10253,"date":"2024-06-18T19:45:00","date_gmt":"2024-06-18T16:45:00","guid":{"rendered":"https:\/\/ozgurkilickesmez.com\/?p=10253"},"modified":"2026-10-13T22:32:09","modified_gmt":"2026-10-13T19:32:09","slug":"chemoembolization","status":"publish","type":"post","link":"https:\/\/ozgurkilickesmez.com\/en\/chemoembolization\/","title":{"rendered":"Chemoembolization (TACE): Procedure, Benefits, Risks and Recovery"},"content":{"rendered":"

Chemoembolization is a targeted treatment for liver tumors, delivering high concentrations of chemotherapy directly to the cancerous tissue while blocking its blood supply. This dual effect maximizes tumor control and minimizes systemic side effects compared to conventional chemotherapy.<\/span><\/p>\n

Transarterial chemoembolization (TACE) is frequently used in patients with hepatocellular carcinoma. By restricting blood flow, it starves the tumor of nutrients while maintaining surrounding liver tissue function, making it a valuable option for non-surgical candidates.<\/span><\/p>\n

The procedure is guided by advanced angiographic imaging, ensuring precise drug delivery. Small embolic particles are used to obstruct the arteries feeding the tumor, enhancing the local therapeutic effect and reducing recurrence rates.<\/span><\/p>\n

Clinical studies demonstrate improved survival and quality of life in patients undergoing chemoembolization. It is often combined with other treatments, such as ablation or targeted therapy, to achieve comprehensive management of liver cancer.<\/span><\/p>\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Things You Need to Know About Kemoembolization (Transarterial Chemoembolization TAKE)<\/td>\n<\/tr>\n
Definition<\/td>\nThe process of treating liver tumors by directly delivering chemotherapy drugs to the tumor-feeding arteries and subsequently embolizing these arteries.<\/td>\n<\/tr>\n
Indications<\/td>\nHepatocellular carcinoma (HCC), colorectal cancer metastases, inoperable liver tumors.<\/td>\n<\/tr>\n
Contraindications<\/td>\nLiver dysfunction, widespread tumor disease, severe coagulopathy, portal vein thrombosis.<\/td>\n<\/tr>\n
Pre-procedure Preparation<\/td>\nBlood tests, imaging studies (MR, CT, angiography), evaluation of the patient\u2019s general health and liver functions, and the requirement for fasting before the procedure.<\/td>\n<\/tr>\n
Procedure Duration<\/td>\nGenerally 1-2 hours.<\/td>\n<\/tr>\n
Type of Anesthesia<\/td>\nLocal anesthesia and sedation.<\/td>\n<\/tr>\n
Procedure Steps<\/td>\n1. Advancing the catheter through the femoral artery into the hepatic artery
\n2. Administration of chemotherapy drugs
\n3. Embolization of the tumor-feeding arteries (with particles or microbeads)
\n4. Removal of the catheter and termination of the procedure<\/td>\n<\/tr>\n
Complications<\/td>\nPost-embolization syndrome (fever, pain, nausea), liver dysfunction, biliary injury, infection, bleeding.<\/td>\n<\/tr>\n
Recovery Time<\/td>\nGenerally a few days to a week; the hospital stay may be 1-2 days.<\/td>\n<\/tr>\n
Success Rate<\/td>\nIn most cases, tumor growth is slowed down or reduced; long-term outcomes depend on the patient\u2019s general health and tumor type.<\/td>\n<\/tr>\n
Alternative Treatments<\/td>\nSurgical resection, radiofrequency ablation (RFA), systemic chemotherapy, radioembolization.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\t
\n\t\t
\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t
\n\t\t\t\n\n
\n\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n
\n\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\"Interventional\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n